Table 2.

Baseline Characteristics of NAFLD and Non-NAFLD Patients in Cohort

Variables	Non-NAFLD	NAFLD	P value
No. of participants	3202	457
Age (years)	44.55 ± 15.57	46.25 ± 15.33	0.029
Gender (n, %)			0.684
Female	1439 (44.94%)	210 (45.95%)
Male	1763 (55.06%)	247 (54.05%)
DBP (mmHg)	72.38 ± 10.19	77.16 ± 10.00	<0.001
SBP (mmHg)	121.04 ± 17.57	128.26 ± 16.40	<0.001
BMI (kg/m2)	21.11 ± 2.02	23.09 ± 1.33	<0.001
LDL-c (mmol/L)	2.11 ± 0.42	2.28 ± 0.44	<0.001
HDL-c (mmol/L)	1.53 ± 0.30	1.38 ± 0.25	<0.001
TG (mmol/L)	0.98 ± 0.30	1.18 ± 0.29	<0.001
TC (mmol/L)	4.33 ± 0.54	4.43 ± 0.53	<0.001
FPG (mmol/L)	5.18 ± 0.77	5.54 ± 1.06	<0.001
UA (μmol/L)	268.21 ± 84.24	304.37 ± 81.12	<0.001
Cr (μmol/L)	82.65 ± 32.11	87.65 ± 19.14	0.001
BUN (mmol/L)	4.60 ± 1.55	4.76 ± 1.47	0.037
DBIL (mmol/L)	2.36 ± 1.23	2.08 ± 0.92	<0.001
TB (mmol/L)	12.23 ± 5.02	12.18 ± 4.81	0.828
GLB (U/L)	29.26 ± 4.13	29.66 ± 4.23	0.055
ALB (U/L)	44.30 ± 2.75	44.26 ± 2.71	0.759
TP (U/L)	73.57 ± 4.36	73.92 ± 4.37	0.103
AST (U/L)	22.50 ± 9.56	24.36 ± 7.83	<0.001
ALT (U/L)	15.00 (12.00–20.00)	20.00 (16.00–27.00)	<0.001
GGT (U/L)	19.00 (15.00–26.00)	26.00 (20.00–37.00)	<0.001
ALP (U/L)	69.87 ± 22.55	76.73 ± 23.22	<0.001
Follow-up (days)	722.00 (666.00–1066.00)	696.00 (371.00–784.00)	<0.001

Notes: Data are n (%), mean ± SD or median (interquartile range).

Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; ALP, alkaline phosphatase; GGT, γ-glutamyltranspeptidase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TP, total protein; ALB, albumin; GLB, globulin; TB, total bilirubin; DBIL, direct bilirubin; BUN, blood urea nitrogen; Cr, creatinine; UA, uric acid; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; NAFLD, non-alcoholic fatty liver disease.